Hexagon Drug Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.27 M
- Revenue Growth -50.78%
- Profit Growth -71.22%
- Ebitda -15.02%
- Net Worth 6.27%
- Total Assets 8.50%
About Hexagon Drug Laboratories
Hexagon Drug Laboratories Pvt Ltd (HDLPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 1984 and has a history of 40 years and two months. Its registered office is in Andhra Pradesh, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹6.27 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chandrasekhar Polaku, Venkata Rellu, Venkata Panasa, and One other member serve as directors at the Company.
Company Details
-
Location
Andhra Pradesh, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110TG1984PTC005115
-
Company No.
005115
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Nov 1984
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hexagon Drug Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chakralatha Polaku
|
Director | 01-Jul-2020 | Current |
|
Chandrasekhar Polaku
|
Director | 10-Jul-2020 | Current |
Venkata Rellu
|
Director | 09-Feb-1987 | Current |
|
Venkata Panasa
|
Director | 06-Jun-1992 | Current |
Financial Performance of Hexagon Drug Laboratories.
Hexagon Drug Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.78% decrease. The company also saw a substantial fall in profitability, with a 71.22% decrease in profit. The company's net worth moved up by a moderate rise of 6.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hexagon Drug Laboratories?
In 2023, Hexagon Drug Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shvintech India LlpChandrasekhar Polaku and Venkata Rellu are mutual person
Charges (Loans)
₹0
₹6.27 M
Charges Breakdown by Lending Institutions
- Andhra Pradesh State Financial Corporation : 0.38 Cr
- State Bank Of Hyderabad : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2002 | State Bank Of Hyderabad | ₹2.50 M | Satisfied |
| 03 Aug 1989 | Andhra Pradesh State Financial Corporation | ₹0.16 M | Satisfied |
| 29 Mar 1989 | Andhra Pradesh State Financial Corporation | ₹0.87 M | Satisfied |
| 14 Jul 1987 | Andhra Pradesh State Financial Corporation | ₹2.74 M | Satisfied |
How Many Employees Work at Hexagon Drug Laboratories?
Unlock and access historical data on people associated with Hexagon Drug Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hexagon Drug Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hexagon Drug Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.